| Literature DB >> 18518952 |
Bing-Fang Hwang1, Jouni Jk Jaakkola, How-Ran Guo.
Abstract
BACKGROUND: Recent findings suggest that exposure to disinfection by-products may increase the risk of birth defects. Previous studies have focused mainly on birth defects in general or groups of defects. The objective of the present study was to assess the effect of water disinfection by-products on the risk of most common specific birth defects.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18518952 PMCID: PMC2467412 DOI: 10.1186/1476-069X-7-23
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
The number of measurements and distribution of TTHMs between three exposure categories and reference category.
| Exposure categories | No of samples | Mean ± SD (μg/L) | Minimum (μg/L) | 25 percentile (μg/L) | Median (μg/L) | 75 percentile (μg/L) | Maximum (μg/L) |
| Reference (TTHMs (0–4 μg/L) | 528 | 3.64 ± 0.95 | .85 | 3.50 | 3.80 | 4.06 | 4.96 |
| Low (TTHMs 5–9 μg/L) | 168 | 5.57 ± 0.96 | 5.00 | 6.25 | 7.15 | 8.05 | 9.50 |
| Medium (TTHMs 10–19 μg/L) | 240 | 16.48 ± 2.94 | 10.68 | 14.95 | 15.57 | 17.57 | 19.53 |
| High (TTHMs 20 ± μg/L) | 228 | 23.24 ± 2.27 | 20.35 | 21.90 | 22.70 | 24.90 | 32.65 |
The prevalence of any birth defect by water region.
| Water region | No. of birth | No. with any birth defects | Prevalence (%) |
| Region I | 111372 | 717 | 0.6 |
| Region II | 106435 | 513 | 0.5 |
| Region III | 49503 | 255 | 0.5 |
| Region IV | 53211 | 293 | 0.6 |
| Region V | 75528 | 378 | 0.5 |
Characteristics of the study population (N = 396,049) according to the categories of exposure, Taiwan, 2001–2003.
| Characteristic | TTHMs (0–4 μg/L) | TTHMs (5–9 μg/L) | TTHMs (10–19 μg/L) | TTHMs (20+ μg/L) | Total N (%) |
| Total | 181,985 (100%) | 55,950 (100%) | 82,797 (100%) | 75,317 (100%) | 396,049 (100%) |
| Gender of infant | |||||
| Male | 95,027 (52.2%) | 29,128 (52.1%) | 43,155 (52.1%) | 39,413 (52.3%) | 206,723(52.2%) |
| Female | 86,958 (47.8%) | 26,822 (47.9%) | 39,642 (47.9%) | 35,904 (47.7%) | 189,326 (47.8%) |
| Maternal age | |||||
| <20 years | 6,419 (3.5%) | 1,838 (3.3%) | 3,499 (4.2%) | 3,461 (4.6%) | 15,217 (3.8%) |
| 20–34 | 156,087 (85.8%) | 46,871 (83.8%) | 72,402 (87.4%) | 65,947 (87.6%) | 341,307 (86.2%) |
| 35- | 19,476 (10.7%) | 7,241 (12.9%) | 6,893 (8.3%) | 5,909 (7.8%) | 39,519 (10.0%) |
| Maternal diabetes mellitus | |||||
| Yes | 418 (0.2%) | 189 (0.3%) | 179 (0.2%) | 144 (0.2%) | 930 (0.2%) |
| No | 181,567 (99.8%) | 55,761 (99.7%) | 82,618 (99.8%) | 75,173 (99.8%) | 395,119 (99.8%) |
| Plurality | |||||
| Singleton | 176,791 (97.1%) | 54,383 (97.2%) | 80,755 (97.5%) | 73,442 (97.5%) | 385,371 (97.3%) |
| Multiple birth | 5,194 (2.9%) | 1,567 (2.8 %) | 2,042 (2.5%) | 1,875 (2.5%) | 10,678 (2.7%) |
| Population density (no of people/km2)* | |||||
| <1000 | 29,881 (16.4%) | 6,697 (12.0%) | 20,387 (24.6%) | 26,392 (35.2%) | 83,357 (21.1%) |
| 1000–5000 | 71,005 (39.0%) | 27,257 (48.7%) | 23,569 (28.5%) | 31,823 (42.5%) | 153,654 (38.8%) |
| >5000 | 81,099 (44.6%) | 21,996 (39.3%) | 38,841 (46.9%) | 16,738 (22.3%) | 158,674 (40.1%) |
Characteristics of included population, excluded population, and total population in Taiwan 2001–2003.
| Characteristics | Included population | Excluded population | Total population | |||
| N | % | N | % | N | % | |
| Total | 396,049 | 100 | 325,240 | 100 | 721,289 | 100 |
| Gender of infant | ||||||
| Male | 206,723 | 52.2 | 170,385 | 52.4 | 377,108 | 52.3 |
| Female | 189,326 | 47.8 | 154,524 | 47.6 | 343,850 | 47.7 |
| Maternal age | ||||||
| <20 years | 15,217 | 3.8 | 16,223 | 5.0 | 31,440 | 4.4 |
| 20–34 | 341,307 | 86.2 | 282,381 | 86.8 | 623,688 | 86.5 |
| 35- | 39,519 | 10.0 | 26,631 | 8.2 | 66,150 | 9.2 |
| Maternal diabetes mellitus | ||||||
| Yes | 930 | 0.2 | 876 | 0.3 | 1,806 | 0.3 |
| No | 395,119 | 99.8 | 324,364 | 99.7 | 719,483 | 99.7 |
| Plurality | ||||||
| Singleton | 385,371 | 97.3 | 316,903 | 97.4 | 702,274 | 97.4 |
| Multiple birth | 10,678 | 2.7 | 8,337 | 2.6 | 19,015 | 2.6 |
| Population density (no of people/km2)* | ||||||
| <1000 | 83,357 | 21.1 | 94,304 | 29.5 | 177,661 | 24.8 |
| 1000–5000 | 153,654 | 38.8 | 144,069 | 45.0 | 297,723 | 41.6 |
| >5000 | 158,674 | 40.1 | 81,817 | 25.6 | 240,491 | 33.6 |
Prevalences and prevalence odds ratios of the most common birth defects according to exposure to trihalomethanes in Taiwan 2001–2003.
| Outcomes | TTHM | TTHM | TTHM | TTHM | |
| 0–4 μg/L | 5–9 μg/L | 10–19 μg/L | 20+ μg/L | ||
| Reference | Low | Medium | High | ||
| Any birth defect | |||||
| N | 2,148 | 978 | 368 | 421 | 381 |
| P (%) | 0.540 | 0.540 | 0.660 | 0.510 | 0.510 |
| OR | 1.00 | 1.23 | 0.95 | 0.94 | |
| aOR (95% CI) | 1.00 | 1.21 (1.07–1.36) | 0.97 (0.86–1.08) | 1.00 (0.89–1.13) | |
| Anencephalus | |||||
| N | 43 | 19 | 9 | 2 | 13 |
| P (%) | 0.011 | 0.010 | 0.016 | 0.002 | 0.017 |
| OR | 1.00 | 1.54 | 0.23 | 1.65 | |
| aOR (95% CI) | 1.00 | 1.59 (0.72–3.52) | 0.23 (0.05–1.01) | 1.96 (0.94–4.07) | |
| Hydrocephalus | |||||
| N | 118 | 58 | 24 | 19 | 17 |
| P (%) | 0.030 | 0.032 | 0.043 | 0.023 | 0.023 |
| OR | 1.00 | 1.35 | 0.72 | 0.71 | |
| aOR (95% CI) | 1.00 | 1.36 (0.85–2.20) | 0.71 (0.42–1.20) | 0.74 (0.43–1.28) | |
| Ventricular septal defects | |||||
| N | 59 | 27 | 6 | 8 | 18 |
| P (%) | 0.015 | 0.015 | 0.011 | 0.010 | 0.024 |
| OR | 1.00 | 0.72 | 0.65 | 1.61 | |
| aOR (95% CI) | 1.00 | 0.74 (0.31–1.80) | 0.65 (0.29–1.43) | 1.81 (0.98–3.35) | |
| Atrial septal defects | |||||
| N | 19 | 8 | 5 | 2 | 4 |
| P (%) | 0.005 | 0.004 | 0.009 | 0.002 | 0.005 |
| OR | 1.00 | 2.03 | 0.55 | 1.21 | |
| aOR (95% CI) | 1.00 | 2.15 (0.70–6.60) | 0.53 (0.11–2.49) | 1.33 (0.39–4.58) | |
| Tetralogy of Fallot | |||||
| N | 24 | 13 | 6 | 3 | 2 |
| P (%) | 0.006 | 0.007 | 0.011 | 0.004 | 0.003 |
| OR | 1.00 | 1.50 | 0.51 | 0.37 | |
| aOR (95% CI) | 1.00 | 1.60 (0.61–4.23) | 0.46 (0.13–1.61) | 0.32 (0.07–1.47) | |
| Cleft lip with/without palate | |||||
| N | 358 | 155 | 55 | 84 | 64 |
| P (%) | 0.090 | 0.085 | 0.098 | 0.101 | 0.085 |
| OR | 1.00 | 1.15 | 1.19 | 1.00 | |
| aOR (95% CI) | 1.00 | 1.15 (0.84–1.56) | 1.20 (0.91–1.55) | 0.98 (0.73–1.32) | |
| Cleft palate | |||||
| N | 129 | 52 | 15 | 28 | 34 |
| P (%) | 0.033 | 0.029 | 0.027 | 0.034 | 0.045 |
| OR | 1.00 | 0.94 | 1.18 | 1.58 | |
| aOR (95% CI) | 1.00 | 0.94 (0.53–1.68) | 1.17 (0.74–1.86) | 1.56 (1.00–2.41) | |
| Renal agenesis & dysgenesis | |||||
| N | 76 | 33 | 14 | 13 | 16 |
| P (%) | 0.019 | 0.018 | 0.025 | 0.016 | 0.021 |
| OR | 1.00 | 1.38 | 0.87 | 1.17 | |
| aOR (95% CI) | 1.00 | 1.33 (0.71–2.48) | 0.92 (0.48–1.75) | 1.27 (0.69–2.33) | |
| Obstructive urinary tract defects | |||||
| N | 49 | 19 | 10 | 10 | 10 |
| P (%) | 0.012 | 0.010 | 0.018 | 0.012 | 0.013 |
| OR | 1.00 | 1.71 | 1.16 | 1.27 | |
| aOR (95% CI) | 1.00 | 1.65 (0.77–3.56) | 1.24 (0.57–2.67) | 1.44 (0.66–3.14) | |
| Hypospadias | |||||
| N | 72 | 43 | 8 | 14 | 7 |
| P (%) | 0.018 | 0.024 | 0.014 | 0.017 | 0.009 |
| OR | 1.00 | 0.61 | 0.72 | 0.39 | |
| aOR (95% CI) | 1.00 | 0.59 (0.28–1.26) | 0.76 (0.41–1.38) | 0.47 (0.21–1.04) | |
| Chromosome anomalies | |||||
| N | 364 | 174 | 72 | 67 | 51 |
| P (%) | 0.092 | 0.096 | 0.129 | 0.081 | 0.068 |
| OR | 1.00 | 1.35 | 0.85 | 0.71 | |
| aOR (95% CI) | 1.00 | 1.25 (0.95–1.65) | 0.93 (0.70–1.24) | 0.90 (0.66–1.24) | |
| Down syndrome | |||||
| N | 166 | 73 | 36 | 30 | 27 |
| P (%) | 0.042 | 0.040 | 0.064 | 0.036 | 0.036 |
| OR | 1.00 | 1.60 | 0.90 | 0.89 | |
| aOR (95% CI) | 1.00 | 1.48 (0.99–2.21) | 1.00 (0.65–1.54) | 1.17 (0.74–1.83) | |
| Trisomy 13 | |||||
| N | 14 | 4 | 2 | 6 | 2 |
| P (%) | 0.004 | 0.002 | 0.004 | 0.007 | 0.003 |
| OR | 1.00 | 1.63 | 3.30 | 1.21 | |
| aOR (95% CI) | 1.00 | 1.56 (0.28–8.55) | 3.36 (0.94–12.0) | 1.12 (0.20–6.29) | |
| Trisomy 18 | |||||
| N | 54 | 23 | 12 | 13 | 6 |
| P (%) | 0.014 | 0.013 | 0.021 | 0.016 | 0.008 |
| OR | 1.00 | 1.70 | 1.24 | 0.63 | |
| aOR (95% CI) | 1.00 | 1.64 (0.81–3.30) | 1.31 (0.66–2.59) | 0.81 (0.33–2.02) |
*cOR: crude odds ratio; aOR: adjusted odds ratio. Logistic regression analysis adjusting for maternal age, plurality, and population density.*Estimates not given for the following rare outcomes: spinal bifida (n = 14) microcephalus (n = 9); endocardial cushion defects (n = 7); transposition of great vessels (n = 12); choanal atresia (n = 2); dysplasia of lung (n = 9); congenital cystic kidney (n = 24).
Summary of the results from previous and present studies focusing on seven most common specific birth defect.
| Sweden 2000 [14] | Norway 2002 [12] | California 2003(1) [11] | California 2003(2) [11] | England and Wales 2007 [13] | Taiwan 2008 | |
| Type of study | Cross-sectional, population-based | Cross-sectional, population-based | Case-control | Case-control | Cross-sectional, population-based | Cross-sectional, population-based |
| Study Population | 115,801 births | 184,676 births | 539 controls | 481 conrols | 2,605,226 births | 396,409 births |
| No of birth Defects | 1,842 | 5,764 | 538 | 265 | 22,828 | 2,148 |
| Exposure | Chlorine dioxide | Chlorination, High color | TTHMs 50–74 μg/l | TTHMs 50–74 μg/l | TTHMs >= 60 μg/l | TTHMs >= 20 μg/l |
| Reference | None | No chlorination, Low color | TTHMs 0 μg/l | TTHMs 0 μg/l | TTHMs <30 μg/l | TTHMs 0–4 μg/l |
| Anencephalus | 0.79 (0.15–4.23) (n = 46) | 0.55 (0.26–1.10) (n = 164) | 1.80 (0.76–4.40) (n = 89) | 1.96 (0.94–4.07) (n = 43) | ||
| Hydorcephalus | 1.50 (0.30–7.30) (n = 36) | 2.70 (0.77–9.51) (n = 68) | 0.74 (0.43–1.28) (n = 118) | |||
| Ventricular septal defects | 1.81 (1.05–3.09) (n = 279) | 1.43 (1.00–2.04) (n = 408) | 1.81 (0.98–3.35) (n = 59) | |||
| Atrial septal Defects | 0.92 (0.24–1.50) (n = 73) | 1.33 (0.39–4.58) (n = 19) | ||||
| Cleft lip with/without palate | 0.85 (0.53–1.38) (n = 248) | 1.90 (0.81–4.50) (n = 117) | 0.94 (0.83–1.06) (n = 2,909) | 0.98 (0.73–1.32) (n = 358) | ||
| Cleft palate | 1.07 (0.35–3.27) (n = 95) | 1.00 (0.32–3.40) (n = 58) | 0.95 (0.76–1.10) (n = 1,929) | 1.56 (1.00–2.41) (n = 129) | ||
| Obstructive urinary tract defects | 1.99 (0.66–5.96) (n = 102) | 1.44 (0.66–3.14) (n = 49) |
* Sweden 2000 [14]; California 2003(1): Shaw et. al. Study 1 [11]; California 2003(1): Shaw et. al. Study 2 [11]; Norway 2007 [12]; England and Wales 2007 [13]; Taiwan 2008: the present study.
A comparison of the results from the present, Sweden, Norway, California, and England and Wales studies.
| Birth defect | Study area | Fixed-Effects Model Summary OR (95 % CI) | Random-Effects Model Summary OR (95% CI) | Q-statistic/P-value* |
| Anencephalus | Norway 2002 | 1.13 (0.74–1.73) | 1.15 (0.56–2.36) | 7.55/0.056 |
| California 2003 (1) | ||||
| California 2003 (2) | ||||
| Taiwan 2008 | ||||
| Norway 2002 | 0.85 (0.51–1.43) | 0.91 (0.40–2.51) | 4.23/0.121 | |
| California 2003 (1) | ||||
| California 2003 (2) | ||||
| Norway 2002 | 0.98 (0.61–1.59) | 0.98 (0.38–2.51) | 6.19/0.045 | |
| California 2003 (1) | ||||
| Taiwan 2008 | ||||
| Norway 2002 | 1.73 (1.01–2.96) | 1.73 (1.01–2.96) | 0.96/0.619 | |
| California 2003 (2) | ||||
| Taiwan 2008 | ||||
| Cleft palate | Norway 2002 | 1.00 (0.87–1.15) | 1.10 (0.82–1.48) | 4.50/0.212 |
| California 2003 (2) | ||||
| Taiwan 2008 | ||||
| England and Wales 2007 | ||||
| Norway 2002 | 1.43 (0.97–2.10) | 1.43 (0.97–2.10) | 0.74/0.690 | |
| California 2003 (2) | ||||
| Taiwan 2008 | ||||
| Norway 2002 | 0.95 (0.83–1.10) | 0.95 (0.83–1.10) | 0.05/0.976 | |
| California 2003 (2) | ||||
| England and Wales 2007 | ||||
| California 2003 (2) | 1.00 (0.87–1.15) | 1.13 (0.77–1.66) | 4.49/0.106 | |
| Taiwan 2008 | ||||
| England and Wales 2007 | ||||
| Cleft lip with/without palate | Norway 2002 | 0.95 (0.85–1.06) | 0.95 (0.85–1.06) | 2.76/0.431 |
| California 2003 (2) | ||||
| Taiwan 2008 | ||||
| England and Wales 2007 | ||||
| Norway 2002 | 1.00 (0.78–1.27) | 1.01 (0.75–1.37) | 2.58/0.276 | |
| California 2003 (2) | ||||
| Taiwan 2008 | ||||
| Norway 2002 | 0.95 (0.84–1.06) | 0.97 (0.76–1.24) | 2.71/0.258 | |
| California 2003 (2) | ||||
| England and Wales 2007 | ||||
| California 2003 (2) | 0.96 (0.86–1.07) | 0.98 (0.82–1.15) | 2.54/0.281 | |
| Taiwan 2008 | ||||
| England and Wales 2007 | ||||
| Ventricular septal defects | Norway 2002 | 1.59 (1.21–2.07) | 1.59 (1.21–2.07) | 0.74/0.692 |
| Taiwan 2008 | ||||
| England and Wales 2007 | ||||
| Norway 2002 | 1.81 (1.21–2.71) | 1.81 (1.21–2.71) | 0.0001/0.99 | |
| Taiwan 2008 | ||||
| Hydrocephalus | Sweden 2000 | 0.95 (0.59–1.50) | 1.21 (0.52–2.81) | 3.76/0.152 |
| Norway 2002 | ||||
| Taiwan 2008 | ||||
| Obstructive urinary tract defects | Norway 2002 | 1.61 (0.85–3.03) | 1.61 (0.85–3.03) | 0.22/0.638 |
| Taiwan 2008 | ||||
| Atrial septal defects | Norway 2002 | 0.97 (0.61–1.52) | 0.97 (0.61–1.52) | 0.30/0.59 |
| Taiwan 2008 |
*P < 0.05 indicates that a random-effects model is more appropriate.
*Sweden 2000 [14]; California 2003(1): Shaw et. al. Study 1 [11]; California 2003(1): Shaw et. al. Study 2 [11] Norway 2007 [12]; England and Wales 2007 [13]; Taiwan 2008: the present study.